The relation between insulin resistance and hemostasis: Pleiotropic genes and common environment

Twin Research

Volumn 6, Issue 2, 2003, Pages 152-161

  De Lange, Marlies ^a   Snieder, Harold ^a,c   Ariëns, Robert A S ^b   Andrew, Toby ^a   Grant, Peter J ^b   Spector, Tim D ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 8; FIBRINOGEN; INSULIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; DIABETES MELLITUS; DIZYGOTIC TWINS; ENVIRONMENTAL FACTOR; FEMALE; GENETIC ANALYSIS; HEMOSTASIS; HEREDITY; HUMAN; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MONOZYGOTIC TWINS; PLEIOTROPY; PRIORITY JOURNAL; RISK FACTOR;

ADOLESCENT; ADULT; AGED; CORONARY DISEASE; ENVIRONMENT; FEMALE; HEMOSTASIS; HUMANS; INSULIN RESISTANCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REGISTRIES; RISK FACTORS;

EID: 0037389836     PISSN: 13690523     EISSN: None     Source Type: Journal    
DOI: 10.1375/136905203321536281     Document Type: Article

References (37)

1. Ariëns, R. A., Kohler, H. P., Mansfield, M. W., & Grant, P. J. (1999). Subunit antigen and activity levels of blood coagulation factor XIII in healthy individuals. Relation to sex, age, smoking, and hypertension. Arteriosclerosis Thrombosis Vascular Biology, 19, 2012-2016.
2. Boomsma, D. I., & Dolan, C. V. (2000). Multivariate QTL analysis using structural equation modelling: a look at power under simple conditions. In T. Spector, H. Snieder, & A. J. MacGregor (Eds.), Advances in twin and sib-pair analysis (pp. 203-218). London: Greenwich Medical Media Ltd.
3. Cesari, M., & Rossi, G. P. (1999). Plasminogen activator inhibitor type 1 in ischemic cardiomyopathy. Arteriosclerosis Thrombosis Vascular Biology, 19, 1378-1386.
4. Clauss, A. (1952). Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematologica, 17, 237-246.
5. de Lange, M., Snieder, H., Ariëns, R. A., Spector, T. D., & Grant, P. J. (2001). The genetics of haemostasis: A twin study. The Lancet, 357, 101-105.
6. Folsom, A. R., Aleksic, N., Park, E., Salomaa, V., Juneja, H., & Wu, K. K. (2001). Prospective study of fibrinolytic factors and incident coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) Study. Arteriosclerosis Thrombosis Vascular Biology, 21, 611-617.
7. Forman, B. M., Chen, J., & Evans, R. M. (1996). The peroxisome proliferator-activated receptors: Ligands and activators. Annals of the New York Academy of Sciences, 804, 266-275.
8. Hammond, C. J., Snieder, H., Spector, T. D., & Gilbert, C. E. (2000). Genetic and environmental factors in age-related nuclear cataracts in monozygotic and dizygotic twins. New England Journal of Medicine, 342, 1786-1790.
9. Hollenbeck, C. B., & Reaven, G. M. (1987). Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. Journal of Clinical Endocrinology and Metabolism, 64, 1169-1173.
10. Hong, Y., Pedersen, N. L., Brismar, K., & de Faire, U. (1997). Genetic and environmental architecture of the features of the insulin-resistance syndrome. American Journal of Human Genetics, 60, 143-152.
11. Jarrett, R. J. (1984). Type 2 (non-insulin-dependent) diabetes mellitus and coronary heart disease - chicken, egg or neither? Diabetologia, 26, 99-102.
12. Jarrett, R. J., & Shipley, M. J. (1988). Type 2 (non-insulin-dependent) diabetes mellitus and cardiovascular disease - Putative association via common antecedents; further evidence from the Whitehall Study. Diabetologia, 31, 737-740.
13. Juhan-Vague, I., Thompson, S., & Jespersen, J. (1993). Involvement of the hemostatic system in the insulin resistance syndrome. Arteriosclerosis and Thrombosis, 13, 1865-1873.
14. Juhan-Vague, I., & Vague, P. (1991). Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis. Diabetologia, 34, 457-462.
15. Kohler, H. P., Mansfield, M. W., Clark, P. S., & Grant, P. J. (1999). Interaction between insulin resistance and factor XIII Val34Leu in patients with coronary artery disease. Thrombosis and Haemostasis, 82, 1202-1203.
16. Kohler, H. P., Stickland, M. H., Ossei-Gerning, N., Carter, A., Mikkola, H., & Grant, P. J. (1998). Association of a common polymorphism in the factor XIII gene with myocardial infarction. Thrombosis and Haemostasis, 79, 8-13.
17. Kyvik, K. O. (2000). Generalisability and assumptions of twin studies. In T. Spector, H. Snieder, & A. J. MacGregor (Eds.), Advances in twin and sib-pair analysis (pp. 67-77). London: Greenwich Medical Media Ltd.
18. Lane, D. A., & Grant, P. J. (2000). Role of haemostatic gene sequence polymorphisms in venous and arterial disease. Blood, 95, 1517-1532.
19. Lange, K., Westlake, J., & Spence, M. (1976). Extensions to pedigree analysis: III. Variance components by the scoring method. Annals of Human Genetics, 39, 485-491.
20. Lehtovirta, M., Kaprio, J., Forsblom, C., Eriksson, J., Tuomilehto, J., & Groop, L. (2000). Insulin sensitivity and insulin secretion in monozygotic and dizygotic twins. Diabetologia, 43, 285-293.
21. Loehlin, J. C. (1996). The Cholesky approach: A cautionary note. Behavior Genetics, 26, 65-69.
22. Mansfield, M. W., Kohler, H. P., Ariëns, R. A., McCormack, L. J., & Grant, P. J. (2000). Circulating levels of coagulation factor XIII in subjects with type 2 diabetes and in their first-degree relatives. Diabetes Care, 23, 703-705.
23. Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985). Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412-419.
24. Meade, T. W., Mellows, S., Brozovic, M., Miller, G. J., Chakrabarti, R. R., North, W. R., et al. (1986). Haemostatic function and ischaemic heart disease: Principal results of the Northwick Park Heart Study. The Lancet, 6(2), 533-537.
25. Meigs, J. B., Mittleman, M. A., Nathan, D. M., Tofler, G. H., Singer, D. E., Murphy-Sheehy, P. M., et al. (2000). Hyperinsulinemia, hyperglycemia, and impaired hemostasis: The Framingham Offspring Study. Journal of the American Medical Association, 283, 221-288.
26. Narkiewicz, K., Chrostowska, M., Kuchta, G., Szczech, R., Welz, A., Rynkiewicz, A., et al. (1997). Genetic influences on insulinemia in normotensive twins. American Journal of Hypertension, 10, 467-470.
27. Neale, M. C., Boker, S. M., Xie, G., & Maes, H. H. (1999). Mx: statistical modeling. MCV Box 900126, Richmond, VA 23298 Department of Psychiatry.
28. Neale, M. C., & Cardon, L. R. (1992). Methodology for genetic studies of twins and families. Dordrecht: Kluwer Academic Publishers.
29. Plomin, R., DeFries, J. C., & McClearn, G. E. (1990). Behavioral genetics: A primer. New York: W.H. Freeman and company.
30. Potter van Loon, B. J., Kluft, C., Radder, J. K., Blankenstein, M. A., & Meinders, A. E. (1993). The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance. Metabolism, 42, 945-949.
31. Raynaud, E., Pérez-Martin, A., Brun, J-P., Aïssa-Benhaddad, A., Fédou, C., & Mercier, J. (2000). Relationship between fibrinogen and insulin resistance. Atherosclerosis, 150, 365-370.
32. Reaven, G. M. (1988). Role of insulin resistance in human disease. Diabetes, 37, 1595-1607.
33. Sluyter, E, Keijser, J. N., Boomsma, D. I., van Doornen, L. J. P., van den Oord, E. J. C. G., & Snieder, H. (2000). Genetics of testosterone and the aggression-hostility-anger (AHA) syndrome: a study of middle-aged male twins. Twin Research, 3, 266-276.
34. Souto, J. C., Almasy, L., Borrell, M., Garí, M., Martínez, E., Mateo, J., et al. (2000). Genetic determinants of hemostasis phenotypes in Spanish families. Circulation, 101, 1546-1551.
35. Stern, M. P. (1995). Diabetes and cardiovascular disease. The "common soil" hypothesis. Diabetes, 44, 369-374.
36. Thompson, S. G., Kienast, J., Pyke, S. D., Haverkate, E, & van de Loo, J. C. (1995). Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. New England Journal of Medicine, 332, 635-641.
37. Van den Oord, E. J. (1999). Method to detect genotype-environment interactions for quantitative trait loci in association studies. American Journal of Epidemiology, 150, 1179-1187.